CCRN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cross Country Healthcare Inc. (CCRN) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company is undergoing a strategic pivot with potential upside if successfully executed, but its recent financial performance is weak, and there are no significant positive catalysts in the short term. The technical indicators are neutral, and there are no strong trading signals or recent influential trades to support immediate action.
The MACD is positive and expanding, indicating a mild bullish trend. RSI is neutral at 60.689, and moving averages are converging, showing no clear directional momentum. The stock is trading near its pivot point of 8.423, with resistance at 8.887 and support at 7.959.
The company has a debt-free balance sheet with $119M in liquidity, enabling strategic investments. The return of co-founder Kevin Clark as CEO brings expertise in technology platform development. The company has announced share buybacks under a $40M authorization, which could support the stock price.
The failed merger with Aya Healthcare has created uncertainty, and the company is in the early stages of a strategic pivot. Analysts have lowered price targets, reflecting cautious sentiment.
In Q3 2025, revenue dropped by 20.65% YoY to $250.05M. Net income fell to -$4.77M, down 286.85% YoY. EPS dropped to -0.15, down 287.50% YoY. Gross margin slightly decreased to 18.73%, down 1.06% YoY.
Analyst ratings are mixed, with most firms maintaining Neutral or Hold ratings. Price targets range from $8.65 to $11, reflecting cautious optimism. Analysts highlight the company's potential upside if its technology-led transformation succeeds but remain cautious due to recent financial underperformance and the failed merger.
